Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients
NCT00781040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 273
Last updated 2019-03-01
Summary
The aim of this study is to find out whether inflammation markers including cardiac markers have predictive value in evaluation of pathogenesis of sepsis in neutropenic haematological patients.
Conditions
Interventions
- OTHER
-
Severe sepsis vs. non-severe sepsis
To compare these two groups
Sponsors & Collaborators
-
Kuopio University Hospital
lead OTHER
Principal Investigators
-
Esa Jantunen, M.D, PhD · Kuopio University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2019-01-01
- Completion
- 2019-01-01
Countries
- Finland
Study Locations
More Related Trials
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Alterations of Immunologic Mediators During Severe Sepsis
NCT00484146 ·Status: TERMINATED
-
Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule
NCT01505478 ·Status: WITHDRAWN
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
The Role of NLR in the Diagnosis and Prognosis of Sepsis
NCT05636202 ·Status: COMPLETED
-
Effects of Acute Systemic Inflammation on Arterial Stiffness and Microcirculation.
NCT01556373 ·Status: COMPLETED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Sepsis Characterization in Kilimanjaro
NCT05139459 ·Status: COMPLETED
-
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
NCT00934011 ·Status: COMPLETED ·Phase: NA
-
Platelet Reactivity in Septic Shock
NCT03716310 ·Status: COMPLETED
-
Molecular Biomarkers for Sepsis
NCT04280354 ·Status: TERMINATED
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT00222222 ·Status: COMPLETED ·Phase: NA
-
Effect of Dapagliflozin on Interleukin 10 in Sepsis
NCT07206160 ·Status: NOT_YET_RECRUITING
-
Acute Phase Proteins as Early Markers in Sepsis
NCT00641355 ·Status: UNKNOWN
-
Neutrophil Phenotypic Profiling and Organ Injury Assessment in Patients With Sepsis
NCT04103268 ·Status: RECRUITING
-
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382 ·Status: WITHDRAWN
-
The Early Coagulopathy for the Prognosis in Sepsis
NCT04582188 ·Status: UNKNOWN
-
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
NCT06491966 ·Status: RECRUITING
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis
NCT07074990 ·Status: COMPLETED ·Phase: NA
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
Risk Factors for Adverse Outcomes in Sepsis
NCT06541600 ·Status: COMPLETED
-
Statin for Immunomudulation in Sepsis
NCT00452608 ·Status: UNKNOWN ·Phase: PHASE2